Stevens Capital Management LP Takeda Pharmaceutical CO LTD Transaction History

Stevens Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$16.71 - $19.9 $234,441 - $279,197	-14,030 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$15.39 - $18.97 $215,921 - $266,149	14,030 New	14,030 $255,000
Q1 2020 Apr 21, 2020	SELL	$13.02 - $20.31 $288,913 - $450,678	-22,190 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$16.88 - $20.83 $133,824 - $165,140	7,928 Added 55.59%	22,190 $438,000
Q3 2019 Nov 08, 2019	BUY	$16.15 - $17.99 $230,331 - $256,573	14,262 New	14,262 $245,000
Q2 2019 Jul 31, 2019	SELL	$16.58 - $20.49 $637,318 - $787,615	-38,439 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$16.7 - $21.52 $641,931 - $827,207	38,439 New	38,439 $783,000

322

70.7M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.3B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.